News from BONESUPPORT A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 22, 2017, 03:00 ET BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection,...


Apr 11, 2017, 02:00 ET BONESUPPORT™ Appoints Michael Diefenbeck as Chief Medical Officer

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...


Mar 16, 2017, 03:00 ET BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...


Mar 14, 2017, 03:00 ET BONESUPPORT™ Extends U.S. Distribution Agreement for CERAMENT™|BONE VOID FILLER

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...


Dec 16, 2016, 09:00 ET BONESUPPORT Confirms Election of Dr. Håkan Björklund as Chairman of the Board

Tone Kvåle, CFO of Nordic Nanovector, elected as a new Board Member BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone...


Dec 13, 2016, 11:54 ET Richard Davies Wins 'Best CEO in the Biomaterials Industry' Award From European CEO Magazine

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...


Dec 13, 2016, 11:54 ET Richard Davies Wins 'Best CEO in the Biomaterials Industry' Award From European CEO Magazine

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...


Oct 26, 2016, 18:01 ET BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT™ Injectable Drug Eluting Bioceramic Platform

-Dr. Håkan Björklund of Tellacq AB, former CEO of Nycomed, becomes Chairman-Elect - CERAMENT BVF, CERAMENT G AND CERAMENT V continue to...


Sep 01, 2016, 09:12 ET BONESUPPORT™'s CERAMENT™|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis - Results From Prospective Study of 100 Patients Published in The Bone and Joint Journal

Single Stage Surgical Procedure Achieves 96% Infection Eradication Rate BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable...


Aug 30, 2016, 09:00 ET BONESUPPORT™'s CERAMENT™|G and CERAMENT™ V to be Featured Extensively at the 35th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Oxford, UK

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection,...


Aug 09, 2016, 09:03 ET BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study

FORTIFY Study to Assess CERAMENT G as Part of Surgical Repair of OpenDiaphyseal Tibial Fractures   BONESUPPORT AB, an emerging leader in...


Mar 01, 2016, 09:30 ET BONESUPPORT™ Announces Availability In Europe Of CERAMENT™|G In 5 mL Volume To Address Growing Market Demand

 BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation...


Mar 01, 2016, 09:30 ET BONESUPPORT™ macht CERAMENT™|G entsprechend der gestiegenen Marktnachfrage in Europa als 5 ml-Größe verfügbar

CERAMENT™|G 5 ml wird für Infektionsmanagement und Prophylaxe bei Verfahren für Diabetisches Fußsyndrom und kleine...


Mar 01, 2016, 09:30 ET BONESUPPORT™ anuncia la disponibilidad en Europa de CERAMENT™|G en un volumen de 5 mL

-  BONESUPPORT™ anuncia la disponibilidad en Europa de CERAMENT™|G en un volumen de 5 mL para hacer frente al aumento creciente de...


Mar 01, 2016, 09:30 ET BONESUPPORT™ annonce la disponibilité en Europe de CERAMENT™|G sous volume de 5 ml afin de répondre à une demande croissante du marché

CERAMENT™|G 5 ml prochainement utilisé dans la gestion des infections et la prophylaxie dans les procédures liées au pied...


Feb 02, 2016, 09:30 ET BONESUPPORT™ Reports Expansion Of Company's CERAMENT™ Drug Eluting Procedure Registry

- CERAMENT™|G registry now includes 230 cases conducted in 18 hospitals across 9 countries - Registry now updated to include...


Feb 02, 2016, 09:30 ET BONESUPPORT™ meldet Ausweitung des Registers für CERAMENT™ Arzneimittel freisetzende Verfahren

- CERAMENT™|G Register zählt jetzt 230 Fälle, die in 18 Krankenhäusern in 9 Ländern durchgeführt...


Feb 02, 2016, 09:30 ET BONESUPPORT™ anuncia la expansión del registro del procedimiento liberador de fármaco CERAMENT™

- El registro CERAMENT™|G incluye ahora 230 casos realizados en 18 hospitales en nueve países - El registro se ha actualizado...


Feb 02, 2016, 09:30 ET BONESUPPORT™ annonce l'extension du registre des procédures de la société portant sur CERAMENT™, un produit à élution de medicaments

- Le registre de CERAMENT™|G comporte désormais 230 cas menés dans 18 hôpitaux, dans 9 pays - Le registre a...


Jan 22, 2016, 09:30 ET BONESUPPORT™ anuncia el nombramiento de Richard Davies, como nuevo consejero delegado

-  BONESUPPORT™ anuncia el nombramiento del veterano de la industria de las ciencias de la vida, Richard Davies, como nuevo consejero...


Jan 22, 2016, 09:30 ET BONESUPPORT™ Announces Appointment Of Life Sciences Industry Veteran, Richard Davies, As New Chief Executive Officer

Mr. Davies Brings over 25 Years of Life Sciences Industry Experience to BONESUPPORT™ Current Chief Executive Officer, Lloyd Diamond, to...


Jan 22, 2016, 09:30 ET BONESUPPORT™ gibt Ernennung von Richard Davies, Veteran der Life-Sciences-Branche, zum neuen Chief Executive Officer bekannt

Herr Davies bringt über 25 Jahre Erfahrung aus der Life-Sciences-Branche zu BONESUPPORT ™ Derzeitiger Chief Executive Officer, Lloyd...


Jan 22, 2016, 09:30 ET BONESUPPORT™ annonce la nomination au poste de PDG du vétéran du secteur des sciences de la vie Richard Davies

M. Davies apportera à BONESUPPORT™ plus de 25 années d'expérience dans le secteur des sciences de la vie Le PDG actuel, Lloyd...


Jan 11, 2016, 09:30 ET BONESUPPORT™ annonce que dorénavant 20 000 patients ont été traités avec CERAMENT™

BONESUPPORT™, un chef de file émergeant dans les substituts osseux injectables pour les traumatismes orthopédiques, les infections...


Jan 11, 2016, 09:30 ET BONESUPPORT™ anuncia que 20.000 pacientes ya están siendo tratados con CERAMENT™

 BONESUPPORT™, un líder emergente en los sustitutos óseos inyectables para trauma ortopédico, infecciones óseas y...